Silvia Bellando-Randone Selected Research

Silvia Bellando-Randone Research Topics

Disease

24	Systemic Scleroderma (Systemic Sclerosis) 10/2022 - 11/2010
7	Interstitial Lung Diseases (Interstitial Lung Disease) 10/2022 - 09/2016
6	digital ulcers 01/2022 - 01/2015
4	COVID-19 01/2022 - 07/2020
3	Connective Tissue Diseases (Connective Tissue Disease) 01/2022 - 11/2020
3	Rheumatoid Arthritis 10/2021 - 10/2014
2	Arthritis (Polyarthritis) 01/2022 - 11/2020
2	Body Weight (Weight, Body) 12/2021 - 09/2017
2	Psoriatic Arthritis 10/2021 - 04/2016
2	Infections 07/2020 - 04/2016
2	Inflammation (Inflammations) 01/2020 - 01/2018
2	Autoimmune Diseases (Autoimmune Disease) 03/2016 - 01/2013
2	Necrosis 01/2015 - 11/2010
2	Ischemia 07/2011 - 11/2010
1	Genetic Predisposition to Disease (Genetic Predisposition) 10/2022
1	Systemic Vasculitis 01/2022
1	Raynaud Disease (Raynaud's Disease) 01/2022
1	Sjogren's Syndrome (Sjogren Syndrome) 01/2022
1	Myositis (Idiopathic Inflammatory Myopathies) 12/2021
1	Neoplasms (Cancer) 11/2021
1	Acidosis 10/2021
1	Musculoskeletal Diseases (Musculoskeletal Disease) 10/2021
1	Ankylosing Spondylitis 10/2021
1	Osteoporosis 10/2021
1	Rheumatic Diseases (Rheumatism) 06/2021
1	Pulmonary Arterial Hypertension 01/2021
1	Diabetes Mellitus 05/2020
1	Dyslipidemias (Dyslipidemia) 05/2020
1	Hypertension (High Blood Pressure) 05/2020
1	Joint Diseases (Joint Disease) 05/2020
1	Cardiac Arrhythmias (Arrythmia) 01/2020
1	Pneumonia (Pneumonitis) 01/2020
1	Glomerulonephritis 02/2018
1	Albuminuria 02/2018
1	Proteinuria 02/2018
1	Edema (Dropsy) 01/2018
1	Reperfusion Injury 01/2018
1	Hypoxia (Hypoxemia) 01/2018
1	Mixed Connective Tissue Disease (MCTD) 09/2016
1	Anterior Uveitis 04/2016
1	Latent Tuberculosis 04/2016
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 04/2016
1	Calcinosis 01/2015
1	Gangrene 01/2015
1	Cicatrix (Scar) 01/2015

Drug/Important Bio-Agent (IBA)

5	AutoantibodiesIBA 10/2022 - 01/2015
5	Biomarkers (Surrogate Marker)IBA 06/2022 - 04/2015
5	Antirheumatic Agents (DMARD)IBA 01/2022 - 05/2020
4	Biological ProductsIBA 10/2021 - 04/2016
4	Pharmaceutical PreparationsIBA 05/2020 - 04/2016
3	beta-cyclodextrin tetradecasulfate (CTDS)IBA 01/2022 - 09/2016
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018 - 07/2011
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 01/2021
2	AntibodiesIBA 11/2021 - 01/2021
2	Monoclonal AntibodiesIBA 10/2021 - 04/2016
2	CytokinesIBA 10/2021 - 01/2020
1	RNA Splicing FactorsIBA 10/2022
1	Arginine (L-Arginine)FDA Link 10/2022
1	Carrier Proteins (Binding Protein)IBA 10/2022
1	Proteins (Proteins, Gene)FDA Link 10/2022
1	Messenger RNA (mRNA)IBA 10/2022
1	Serine (L-Serine)FDA Link 10/2022
1	Nuclear Antigens (Extractable Nuclear Antigens)IBA 01/2022
1	Antinuclear AntibodiesIBA 01/2022
1	SteroidsIBA 01/2022
1	IgA receptor (protein B)IBA 01/2022
1	Intravenous Immunoglobulins (IVIG)FDA Link 12/2021
1	Urokinase Plasminogen Activator ReceptorsIBA 10/2021
1	Denosumab FDA Link 10/2021
1	Interleukin-17 (Interleukin 17)IBA 10/2021
1	Carbon MonoxideIBA 01/2021
1	Chloroquine (Aralen)FDA LinkGeneric 11/2020
1	Methotrexate (Mexate)FDA LinkGeneric 11/2020
1	Hydroxyl RadicalIBA 11/2020
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2020
1	LipidsIBA 01/2020
1	SolutionsIBA 01/2020
1	GadoliniumIBA 01/2020
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2020
1	Docosahexaenoic AcidsIBA 01/2020
1	Eicosapentaenoic AcidIBA 01/2020
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 02/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2018
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 12/2017
1	Iloprost (Ventavis)FDA Link 09/2017
1	Ligases (Synthetase)IBA 09/2016
1	Rituximab (Mabthera)FDA Link 09/2016
1	Abatacept (Orencia)FDA Link 04/2016
1	Ustekinumab (CNTO 1275)FDA Link 04/2016
1	tocilizumab (atlizumab)FDA Link 04/2016
1	Neuropilin-1IBA 01/2016
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2016
1	plexinIBA 08/2015
1	Semaphorins (Semaphorin)IBA 08/2015
1	Bosentan (Tracleer)FDA Link 07/2015
1	trioctyl phosphine oxide (TOPO)IBA 01/2015

Therapy/Procedure

6	Therapeutics 12/2021 - 01/2012
2	Biological Therapy 05/2020 - 04/2016
1	Precision Medicine 06/2021